Actively Recruiting
Using a Blood Test to Monitor Metastatic Breast Cancer Treatment
Led by Dr. Christopher Mueller · Updated on 2025-07-25
150
Participants Needed
2
Research Sites
127 weeks
Total Duration
On this page
Sponsors
D
Dr. Christopher Mueller
Lead Sponsor
C
Canadian Institutes of Health Research (CIHR)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this observational study is to assess the effectiveness of the mDETECT breast cancer blood test at monitoring treatment response in women with metastatic breast cancer undergoing treatment.
CONDITIONS
Official Title
Using a Blood Test to Monitor Metastatic Breast Cancer Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult women (≥ 18 years of age) with a confirmed diagnosis of breast adenocarcinoma
- Evidence of recurrent or metastatic breast cancer not suitable for surgery or radiation with curative intent
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Kingston Health Sciences Centre - Cancer Centre of Southeastern Ontario
Kingston, Ontario, Canada, K7L 5P9
Actively Recruiting
2
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada, M4N 3M5
Actively Recruiting
Research Team
C
Christopher R Mueller, Ph.D.
CONTACT
K
Keira Frosst
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here